Abstract
In order to study mechanisms of progression of mouse mammary tumor virus (MMTV)-induced pregnancy-dependent mammary lesions, we removed and serially transplanted 17 small tumors detected in MMTV-infected pregnant females. This gave rise to the same number of 'in vivo' tumor lines. Hormone-dependency of the passages was determined by comparing tumor development in multiparous versus virgin hosts. We found that the first passages of most of these lesions (11/17) required pregnancy to grow. However, all these tumor lines lost their hormone-dependence through successive passages. The original pregnancy-dependent lesions were mostly multiclonal and showed high levels of estrogen and progesterone receptors. Alternatively, pregnancy-independent tumors arose as clonal dominant populations exhibiting a lower hormone receptor content. Our data show that the progression of hormone-dependent MMTV-induced mammary tumors is an irreversible process associated with the appearance of additional MMTV insertional events as well as alterations in the composition of the tumor cell population.
Similar content being viewed by others
References
Callahan R, Smith GH: MMTV-induced mammary tumorigen-esis: gene discovery, progression to malignancy and cellular pathways. Oncogene 19: 992–1001, 2000
Callahan R: MMTV-induced mutations in mouse mammary tumors: their potential relevance to human breast cancer. Breast Cancer Res Treat 39: 33–44, 1996
Aidells BD, Daniels CW: Hormone-dependent mammary tu-mors in strain GR/A mice: alteration between ductal and tumourous phases of growth during serial transplantation. J Natl Cancer Inst 52: 1855–1863, 1974
Peters G, Lee AE, Dickson C: Activation of a cellular gene by mouse mammary tumor virus may occur early in mammary tumor development. Nature 309: 273–275, 1984
Michalides R, Wagenaar E, Sluyser M: Mammary tumor virus DNA as a marker for genotypic variance within hormone-responsive GR mouse mammary tumors. Cancer Res: 42: 1154–1158, 1982
Kordon EC, Smith GH: An entire functional mammary gland may comprise the progeny from a single cell. Development 125: 1921–1930, 1998
Withers-Ward ES, Kitamura Y, Barnes JP, Coffin JM: Distri-bution of targets for avian retrovirus DNA integration in vivo. Genes Dev 8: 1473–1487, 1994
Golovkina T, Piazzon I, Nepomnaschy I, Buggiano V, Olano-Vela M, Ross RJ: Generation of a tumorigenic milk-borne mouse mammary tumor virus by recombination between an endogenous and exogenous virus. J Virol 71: 3895–3903, 1997
Buggiano V, Goldman A, Nepomnaschy I, Bekinschtein P, Berger P, Lombardi G, Deroche A, Francisco MV, Piazzon I: Characterization of two infectious mammary tumor viruses: superantigenicity and tumorigenicity. Scand J Immunol 49: 269–277, 1999
Buggiano V, Schere-Levy C, Abe K, Vanzulli S, Piazzon I, Smith G, Kordon EC: Impairment of mammary lobular development induced by expression of TGF 1 under the con-trol of WAP promoter does not suppress tumorigenesis in MMTV-infected transgenic mice. Int J Cancer 92: 568–576, 2001
Southern RM: Detection of specific sequences among DNA fragment separated by gel electrophoresis. J Mol Biol 98: 503–517, 1975
Sluyser M, Moncharment B, Van Der Valk A, DeGoeij CC, Evers SG: Different int-1 region DNA rearrangements within different zones of a single mouse mammary tumor. Virology 163: 11–18, 1988
Sarkar NH: Clonal variations among multiple primary mam-mary tumors and within a tumor of individual mice: insertion mutations of INT oncogenes. Virology 212: 490–499, 1995
Cardiff RD, Fanning TG, Morris DW, Ashley RL, Faulkin LJ: Restriction endonuclease studies of hyperplastic outgrowth lines from BALB/cfC3H mouse hyperplastic mammary nod-ules. Cancer Res 41: 3024–3029, 1981
Satyaswaroop PG, Sivarajah A, Zaino RJ, Mortel R: Hormonal control of growth of human endometrial carcinoma in the nude mouse model. In: Bresciani F, King RJB, Lippman ME, Raynaud JP (eds) Progress in Cancer Research and Therapy. Vol 35, Hormones and Cancer 3, Raven Press, New York, 1988, pp 430–435
Dabre PD, King RJB: Progression to steroid autonomy in S115 mouse mammary tumor cells: role of DNA methylation. J Cell Biol 99: 1410–1415, 1984
Kordon E, Lanari C, Meiss R, Elizalde P, Charreau E, Dosne Pasqualini C: Hormone-dependence of a mouse mammary tumor line induced in vivo by medroxyprogesterone acetate. Breast Cancer Res Treat 17: 33–43, 1990
Dabre PD, King RJB: Progression to steroid insensitivity can occur irrespective of the presence of functional steroid receptors. Cell 51: 521–528, 1987
Kordon E, Guerra F, Molinolo A, Elizalde P, Charreau E, Dosne Pasqualini C, Montecchia F, Pazos P, Dran G, Lanari C: Effect of sialoadenectomy on medroxyprogesterone-acetate-induced mammary carcinogenesis in BALB/c mice. Correlation between histology and epidermal-growth-factor receptor content. Int J Can 59: 196–203, 1994
Sluyser M, Van Nie R: Estrogen receptor content and hormone-responsive growth of mouse mammary tumors. Can-cer Res 34: 3253–3257, 1974
Heston WE, Vlahakis GM: Mammary tumors, plaques and hy-perplastic alveolar nodules in various combinations of mouse inbred strains and the different lines of the mammary tumor virus. Int J Cancer 7: 141–148, 1971
Aghorne C, Thomas M, Lagarde A, Kerbel RS, Breitman ML: Genetic evidence for progressive selection and overgrowth of primary tumors by metastatic cell subpopulations. Cancer Res 48: 6109–6114, 1988
Clarke RB, Howell A, Potten CS, Anderson E: Dissociation between steroid receptor expression and cell proliferation in the human breast. Cancer Res 57: 4987–4991, 1997
Shoker BS, Jarvis C, Clarke RB, Anderson E, Hewlett, Davies MPA, Ross Sibson D, Sloane JP: Estrogen receptor-positive proliferating cells in the normal and precancerous breast. Am J Pathol 155: 1811–1815, 1999
Haslam SZ, Shyamala G: Progesterone receptor in normal mammary gland: receptor modulations in relation to differen-tiation. J Cell Biol 86: 730–737, 1980
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Buggiano, V., Schere Levy, C., Gattelli, A. et al. Origin and Progression of Pregnancy-Dependent Mammary Tumors Induced by New Mouse Mammary Tumor Virus Variants. Breast Cancer Res Treat 75, 191–202 (2002). https://doi.org/10.1023/A:1019932516887
Issue Date:
DOI: https://doi.org/10.1023/A:1019932516887